Antibiotice Ia (ATB) — Tangible Net Worth Ratio
Antibiotice Ia (ATB) has a Tangible Net Worth Ratio of 91.6% as of June 2026. This metric is calculated by deducting intangible assets (RON78.56 Million) from net assets (RON930.75 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Antibiotice Ia to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Antibiotice Ia Tangible Net Worth Ratio (2020–2025)
This chart shows how Antibiotice Ia's Tangible Net Worth Ratio has changed across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 91.6%, reflecting net assets of RON930.75 Million with intangible assets of RON78.56 Million RON.
Annual Tangible Net Worth Ratio for Antibiotice Ia (2020–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Antibiotice Ia from 2020 to 2025, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ATB stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (RON) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.5% | RON932.07 Million | RON69.95 Million | RON1.39 Billion | ▼ -1.3 pp |
| 2024 | 93.8% | RON894.31 Million | RON55.17 Million | RON1.28 Billion | ▼ -0.8 pp |
| 2023 | 94.6% | RON846.96 Million | RON45.53 Million | RON1.14 Billion | ▲ +0.2 pp |
| 2022 | 94.4% | RON641.43 Million | RON35.80 Million | RON856.47 Million | ▼ -0.6 pp |
| 2021 | 95.1% | RON604.99 Million | RON29.84 Million | RON895.39 Million | ▼ -1.5 pp |
| 2020 | 96.6% | RON577.27 Million | RON19.71 Million | RON863.00 Million | — |